- $2.24bn
- $1.79bn
- $4.32bn
- 30
- 51
- 20
- 25
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.38 | ||
| Price to Tang. Book | 3.9 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.52 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -30.4% | ||
| Return on Equity | -22.91% | ||
| Operating Margin | -5.38% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 794.41 | 1,218.33 | 1,521.49 | 2,388.22 | 4,316.36 | 6,504.04 | 8,093.56 | 52.68% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
agilon health, inc. is a healthcare company. It enables primary care physicians (PCP) to be the agents for change in the communities they serve. Through its combination of the agilon platform, a long-term partnership model with existing physician groups and a growing network of like-minded physicians, it offers healthcare for seniors across communities throughout the United States. Its model operates by primarily forming risk-bearing entities (RBEs) within local geographies, that enter into arrangements with payors providing for monthly payments to manage the total healthcare needs of its physician partners’ attributed patients (or global capitation arrangements). It focuses on community-based physician groups and is built around three key elements: agilon’s platform, agilon’s long-term physician partnership approach, and agilon’s network. The agilon platform is holistic in supporting the rapid transition to a Total Care Model with technology, people, process and capital.
Directors
- Ronald Williams NEC (71)
- Steven Sell PRE (54)
- Ravi Sachdev VCH (44)
- Timothy Bensley CFO (61)
- Chris Casler CHO
- Girish Venkatachaliah CTO (47)
- Ben Shaker CMO (38)
- Veeral Desai OTH (40)
- Lisa Dombro OTH (53)
- Theodore Halkias OTH (53)
- Benjamin Kornitzer OTH (43)
- Karen Mcloughlin DRC (56)
- Richard Schnall DRC (51)
- Derek Strum DRC (42)
- William Wulf DRC (61)
- Michelle Gourdine IND (58)
- Sharad Mansukani IND (52)
- Clay Richards IND (46)
- Michael Smith IND (72)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- April 21st, 2017
- Public Since
- April 15th, 2021
- No. of Shareholders
- 673
- No. of Employees
- 1,117
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
New York Stock Exchange- Shares in Issue
- 409,541,664
- Address
- 6210 E Hwy 290, Suite 450, AUSTIN, 78723
- Web
- https://www.agilonhealth.com/
- Phone
- +1 5622563800
- Contact
- Matthew Gillmor
- Auditors
- Ernst & Young LLP
Upcoming Events for AGL
agilon health inc Annual Shareholders Meeting
agilon health inc Annual Shareholders Meeting
Q2 2024 agilon health inc Earnings Release
Similar to AGL
AMERICAN WELL
New York Stock Exchange
AMN Healthcare Services
New York Stock Exchange
Ati Physical Therapy
New York Stock Exchange
Auna SAA
New York Stock Exchange
Brookdale Senior Living
New York Stock Exchange
FAQ
What is the Agilon Health share price?
As of Today at 19:00 UTC, shares in Agilon Health are trading at $5.46. This share price information is delayed by 15 minutes.
How has the Agilon Health share price performed this year?
Shares in Agilon Health last closed at $5.46 and the price had moved by -78.1% over the past 365 days. In terms of relative price strength the Agilon Health share price has underperformed the S&P500 Index by -81.77% over the past year.
What are the analyst and broker recommendations for Agilon Health?
The overall consensus recommendation for Agilon Health is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Agilon Health dividend yield?
Agilon Health does not currently pay a dividend.
Does Agilon Health pay a dividend?
Agilon Health does not currently pay a dividend.
When does Agilon Health next pay dividends?
Agilon Health does not currently pay a dividend.
How do I buy Agilon Health shares?
To buy shares in Agilon Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Agilon Health?
As of the previous close price of $5.46, shares in Agilon Health had a market capitalisation of $2.24bn.
Where are Agilon Health shares listed?
Here are the trading details for Agilon Health:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: AGL
What kind of share is Agilon Health?
Based on an overall assessment of its quality, value and momentum Agilon Health is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Agilon Health share price forecast for 2024?
The analyst consensus target price for shares in Agilon Health is $8.03. That is 47.07% above the last closing price of $5.46.
Analysts covering Agilon Health currently have a consensus Earnings Per Share (EPS) forecast of -$0.31 for the next financial year.
What is the trend in the Agilon Health share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Agilon Health. Over the past six months, its share price has underperformed the S&P500 Index by -76.03%.
As of the last closing price of $5.46, shares in Agilon Health were trading -56.3% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Agilon Health PE Ratio?
The Agilon Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $5.46.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Agilon Health?
Agilon Health's management team is headed by:
- Ronald Williams - NEC
- Steven Sell - PRE
- Ravi Sachdev - VCH
- Timothy Bensley - CFO
- Chris Casler - CHO
- Girish Venkatachaliah - CTO
- Ben Shaker - CMO
- Veeral Desai - OTH
- Lisa Dombro - OTH
- Theodore Halkias - OTH
- Benjamin Kornitzer - OTH
- Karen Mcloughlin - DRC
- Richard Schnall - DRC
- Derek Strum - DRC
- William Wulf - DRC
- Michelle Gourdine - IND
- Sharad Mansukani - IND
- Clay Richards - IND
- Michael Smith - IND